Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene : a cystic fibrosis mutation of slavic origin common in Central and East Europe

• Published in: Human genetics 2000-03, Vol.106 (3), p.259-268
• Main Authors: DÖRK, T, MACEK, M. JR, ZEMKOVA, D, GINTER, E, PETROVA, N. V, IVASCHENKO, T, BARANOV, V, WITT, M, POGORZELSKI, A, BAL, J, ZEKANOWSKY, C, WAGNER, K, MEKUS, F, STUHRMANN, M, BAUER, I, SEYDEWITZ, H. H, NEUMANN, T, JAKUBICZKA, S, KRAUS, C, THAMM, B, NECHIPORENKO, M, LIVSHITS, L, MOSSE, N, TÜMMLER, B, TSUKERMAN, G, KADASI, L, RAVNIK-GLAVAC, M, GLAVAC, D, KOMEL, R, VOUK, K, KUCINSKAS, V, KRUMINA, A, TEDER, M, KOCHEVA, S, TZOUNTZOURIS, J, EFREMOV, G. D, ONAY, T, KIRDAR, B, MALONE, G, SCHWARZ, M, ZHAOQING ZHOU, FRIEDMAN, K. J, CARLES, S, CLAUSTRES, M, BOZON, D, CASALS, T, VERLINGUE, C, FEREC, C, TZETIS, M, KANAVAKIS, E, CUPPENS, H, BOMBIERI, C, PIGNATTI, P. F, SANGIUOLO, F, JORDANOVA, A, KUSIC, J, KREBSOVA, A, KOUDOVA, M, SAKMARYOVA, I. SR, VAVROVA, V
• Format: Article
• Language: English
• Subjects: Alleles; Biological and medical sciences; Child; Child, Preschool; Cystic Fibrosis - epidemiology; Cystic Fibrosis - genetics; Cystic Fibrosis Transmembrane Conductance Regulator - genetics; DNA Mutational Analysis; Europe - epidemiology; Female; Gastroenterology. Liver. Pancreas. Abdomen; Gene Frequency; Humans; Infant; Infant, Newborn; Liver. Biliary tract. Portal circulation. Exocrine pancreas; Male; Medical sciences; Other diseases. Semiology; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Sequence Deletion
• ISSN: 0340-6717; 1432-1203
• DOI: 10.1007/s004390000246

We report a large genomic deletion of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, viz., a deletion that is frequently observed in Central and Eastern Europe. The mutation, termed CFTRdele2,3(21 kb), deletes 21,080 bp spanning introns 1-3 of the CFTR gene. Transcript analyses have revealed that this deletion results in the loss of exons 2 and 3 in epithelial CFTR mRNA, thereby producing a premature termination signal within exon 4. In order to develop a simple polymerase chain reaction assay for this allele, we defined the end-points of the deletion at the DNA sequence level. We next screened for this mutation in a representative set of European and European-derived populations. Some 197 CF patients, including seven homozygotes, bearing this mutation have been identified during the course of our study. Clinical evaluation of CFTRdele2,3(21 kb) homozygotes and a comparison of compound heterozygotes for deltaF508/CFTRdele2,3(21 kb) with pairwise-matched deltaF508 homozygotes indicate that this deletion represents a severe mutation associated with pancreatic insufficiency and early age at diagnosis. Current data show that the mutation is particularly common in Czech (6.4% of all CF chromosomes), Russian (5.2%), Belorussian (3.3%), Austrian (2.6%), German (1.5%), Polish (1.5%), Slovenian (1.5%), Ukrainian (1.2%), and Slovak patients (1.1%). It has also been found in Lithuania, Latvia, Macedonia and Greece and has sporadically been observed in Canada, USA, France, Spain, Turkey, and UK, but not in CF patients from Bulgaria, Croatia, Romania or Serbia. Haplotype analysis has identified the same extragenic CF-haplotype XV-2c/KM. 19 "A" and the same infrequent intragenic microsatellite haplotype 16-33-13 (IVS8CA-IVS 17bTA-IVS 17bCA) in all examined CFTRdele2,3(21 kb) chromosomes, suggesting a common origin for this deletion. We conclude that the 21-kb deletion is a frequent and severe CF mutation in populations of Eastern- and Western-Slavic descent.